0001209191-22-047888.txt : 20220829 0001209191-22-047888.hdr.sgml : 20220829 20220829170356 ACCESSION NUMBER: 0001209191-22-047888 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220825 FILED AS OF DATE: 20220829 DATE AS OF CHANGE: 20220829 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Andriole Michael T. CENTRAL INDEX KEY: 0001698751 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35867 FILM NUMBER: 221211915 MAIL ADDRESS: STREET 1: C/O ENDOCYTE, INC. STREET 2: 3000 KENT AVENUE, SUITE A1-100 CITY: WEST LAFAYETTE STATE: IN ZIP: 47906 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHIMERIX INC CENTRAL INDEX KEY: 0001117480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330903395 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 BUSINESS PHONE: 919.806.1074 MAIL ADDRESS: STREET 1: 2505 MERIDIAN PARKWAY, SUITE 100 CITY: DURHAM STATE: NC ZIP: 27713 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-25 0 0001117480 CHIMERIX INC CMRX 0001698751 Andriole Michael T. 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 0 1 0 0 Chief Business Officer and CFO Common Stock 2022-08-25 4 M 0 50000 2.09 A 262724 D Employee Stock Option (Right to Buy) 2.09 2022-08-25 4 M 0 50000 0.00 D 2029-04-07 Common Stock 50000 450000 D One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter. /s/ Michael Alrutz, Attorney-in-fact 2022-08-29